DL-Methionine-DL-sulfoximine

CAS : 1982-67-8

Ref. 3D-FM57660

Informations sur le produit

• Nom: DL-Methionine-DL-sulfoximine
• Synonymes: (2R)-2-amino-4-(S-methylsulfonimidoyl)butanoic acid, 2-Amino-4-(Methylsulfonimidoyl)Butanoic Acid, 2-Amino-4-(S-methylsulfonimidoyl)butanoic acid, 2-Amino-4-(S-methylsulphonimidoyl)butyric acid, 2-Amino-4-[imino(methyl)oxo-λ6-sulfanyl]butanoic acid, 2-Azaniumyl-4-(methylsulfonimidoyl)butanoate, <span class="text-smallcaps">DL</smallcap>-Methionine-<smallcap>DL</span>-sulfoximine, Ai3-62723, Butanoic acid, 2-amino-4-(S-methylsulfonimidoyl)-, Ccris 5096, Methionine sulfoximine, Methionine-DL-sulfoximine, DL-, Methionine-RS-sulfoximine, L-, Sulfoximine, S-(3-amino-3-carboxypropyl)-S-methyl-, <span class="text-smallcaps">DL</span>-, Sulfoximine, S-(3-amino-3-carboxypropyl)-S-methyl-, DL-

Description

DL-Methionine sulfoximine is a drug that blocks the synthesis of glutathione, an important antioxidant and detoxifying agent. DL-Methionine sulfoximine may be useful in preventing or treating eye disorders, such as age-related macular degeneration and retinitis pigmentosa. It also has been shown to have beneficial effects in animal models of epilepsy, Alzheimer’s disease, Parkinson's disease, and stroke. DL-Methionine sulfoximine has been shown to have beneficial effects in animal models of epilepsy, Alzheimer’s disease, Parkinson's disease, and stroke. This drug is being studied for its potential use in metabolic disorders such as diabetes and obesity.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 180.23 g/mol
• Formule: C₅H₁₂N₂O₃S
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder
• InChI: InChI=1S/C5H12N2O3S/c1-11(7,10)3-2-4(6)5(8)9/h4,7H,2-3,6H2,1H3,(H,8,9)
• Code InChI: InChIKey=SXTAYKAGBXMACB-UHFFFAOYSA-N
• SMILES: CS(=N)(=O)CCC(N)C(=O)O